Last reviewed · How we verify

NCT05924711

"Association of Peri-implantitis and Maxillary Sinusitis: a Case-control Study".

Status unknown Last updated 29 June 2023
What this trial tests

trial testing Retrospective analysis of demographic and radiographic data previously obtained from the patient. in Peri-Implantitis in 40 participants. Status unknown.

Timeline
6 June 2023
Primary endpoint
5 July 2023
15 July 2023

Quick facts

Lead sponsorUniversitat Internacional de Catalunya
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment40
Start date6 June 2023
Primary completion5 July 2023
Estimated completion15 July 2023
Sites2 locations across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universitat Internacional de Catalunya — full company profile →

Who can join

Adults 18 to 80, any sex, with Peri-Implantitis or Sinusitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Scientific evidence regarding the influence of peri-implantitis on Schneider's membrane thickening is scarce and limited. Similarly, to date, there is no literature documenting the resolution of implant-associated maxillary sinusitis with peri-implantitis after treatment of peri-implantitis or removal of the implant. Therefore, the aim of this case-control study is to investigate the association between peri-implantitis and maxillary sinusitis. On the other hand, the changes that occur at the level of the maxillary sinus membrane after treatment of peri-implantitis or after implant explantation will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Peri-Implantitis

Currently open trials in the same condition.

Other Universitat Internacional de Catalunya trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05924711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing